New product

Oxymetholone Tablets

89,00€

BANK WIRE & BITCOIN
BANK WIRE & BITCOIN

Oxymetholone Tablets


Each uncoated tablet contains 50 mg of Oxymetholone
Oxymetholone Tablets USP:
Each uncoated tablet contains:
Oxymetholone USP 50mg


DESCRIPTION:
Oxymetholone tablets contain 50mg of the anabolic steroid oxymetholone.
Indications and Uses:
When oxymetholone is indicated in proper doses for short periods and
with appropriate diet to patients with cachexia or debilitating diseases,
they may produce anabolic eff ects without clinical signs of virilism. The
oxymetholone have been used in patients recovering from surgery, infections,
burns, fractures, ameciating diseases, and severe traumatic injuries.
It also have been given to patients with increased catabolism due to proilonged
coricosteroid therapy, but objective evidence of improvement in
patients with senile or corticosteroid-induced osteoporosis has not been
demonstrated. It is used mainly in the treatment of anaemias such as aplastic
anaemias.
CLINICAL PHARMACOLOGY:
Anabolic steroids are synthetic derivates of testosterone. Certain clinical
eff ects and adverse reactions demonstrate the androgenie properties of
this class of drugs. Complete dissociation of anabolic and androgenic effects
has not been achieved. The actions of anabolic steroids are therefore
similar to those of male sex hormones with the possibility of causing serious
disturbances of growth and sexual development if given to young
children. Anabolic steroids suppress the gonadotropic functions of the
potuitary and may exert a direct eff ect upon the testes.
During exogenous administration of anabolic androgens, endogenous
testosterone release is inhibited through inhibition of pituitary luteinizing
hormone (LH). At large doses, spermatogenesis may be suppressed through
feedback inhibitionofpituitary follicle-stimulatinghormone (FSH).
CONTRAINDICATIONS:
Known or suspected carcinoma of the prostate or the male breast. Carcinoma
of the breast in females with hypercalcemia (androgenic anabolic
steroids may stimulate osteolytic bone resorption).
Oxymetholone should not be given during pregnancy, because of possible
mascufi nization of the fetus. It should also be avoided in women who
are breast-feeding. Anabolic steroids have been reported to increase lowdensity
lipoproteins and decrease high-density lipoproteins. These levels
revert to normaion discontinuation.
ADVERSE REACTIONS:
The following adverse reactions have been associated with the use of anabolic
steroids:
Hepatic: Cholastic jaudice with, rarely, hepatic necrosis and death. Hepatocefl
ular neoplasms and peliosis hepatis with long-term therapy. Reversible
changes in liver function tests also occur induding increased bromsulfophthalein
(SSP) retention, and increases in serum bilirubin, aspartate aminotransferase
(AST, SGOTT) and alkaline phosphatase.
In mates:
Prepubertal: Phallic enlargement and increased freguency or persistence
of erections.
Postpubertal: Inhibition of testicula function, testicular atrophy and oligospermia,
impotence, chronic priapism, epididymitis, and bladder irritability.
In females: Clitoral enlargement, menstrual irregularities.
CNS: Habituation, excitation, insomnia, depression, and changes in libido.
Hematologic: Bleeding in patients on concomjtant anticoagulant therapy.
Breast: Gynecomastia.
Larynx: Deepening of the voice in females.
Hair: Hirsutism and male pattern baldness in females. Skin: Acne (expecially
in females and prepubertal males)
Skeletal: Premature closure of epiphyses in children.
PRECAUTIONS:
Fluid and electrolytes: Edema, retention of serum electrolytes (sodium
chlo-ride, potassium, phosphate, calcium).
Metabolic/Endocrine: Decreased glucose tolerance increased creatinine
excretion, increased serum levels of creatinine phosphokinase (CPK). Masculinization
of the fetus. Inhibition of gonadotropin secretion.
DRUG INTERACTIONS:
Anticoagulants:
Anabolic steroids may increase sesitivity to oral anticoagulants. Dosage of
the anticoagulant may have to be decreased in order to maintain desired
prothrombin time. Patients receiving oral anticoagulant therapy require
closemonitoring, especially when anabolic steroids are started or stopped.
Oral hypologlycemic agents:
Oxymetholone may inhibit the metabolism of oral hypoglycemic agents.
Adrenal steroids or ACTH:
In patients with edema, concomitant administration with adrenal cortical
steroids or ACTH may increase the edema.
DOSAGE AND ADMINISTRATION:
The usual adult dosage of Oxymetholone is 1-5mg/kg body weight per
day. The usual eff ective dose is 1-2mg/kg/day but higher doses may be
required and the doses should be individualized.
PRESENTATION:
Tablets of 50mg, bottle of 100 tablets.
STORAGE:
Store in a cool dry place. Protect from light.
Prescription Medicine
Oxymetholone Tablets USP
Each uncoated tablet contains 50 mg of Oxymetholone

4 other products in the same category: